{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T16:52:41Z","timestamp":1794934361274,"version":"4.9.1"},"reference-count":200,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jhltonline.org","clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Heart and Lung Transplantation"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.healun.2024.04.065","type":"journal-article","created":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T06:27:53Z","timestamp":1718346473000},"page":"1199-1234","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["An ISHLT consensus statement on strategies to prevent\u00a0and manage hemocompatibility related adverse events in patients with a durable, continuous-flow ventricular assist device"],"prefix":"10.1016","volume":"43","author":[{"given":"Ian B.","family":"Hollis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas L.","family":"Jennings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selim","family":"Krim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8287-2571","authenticated-orcid":false,"given":"Van-Khue","family":"Ton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1681-9187","authenticated-orcid":false,"given":"Anique","family":"Ducharme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0791-6594","authenticated-orcid":false,"given":"Jennifer","family":"Cowger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Looby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.J.","family":"Eulert-Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7026-3058","authenticated-orcid":false,"given":"Neha","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ed","family":"Horn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirnela","family":"Byku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4220-5293","authenticated-orcid":false,"given":"C.J.","family":"Michaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indranee","family":"Rajapreyar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassandra","family":"Vale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Cosgrove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Hernandez-Montfort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Otero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2834-8493","authenticated-orcid":false,"given":"Amanda","family":"Ingemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6278-2528","authenticated-orcid":false,"given":"Shashi","family":"Raj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6437-849X","authenticated-orcid":false,"given":"Phillip","family":"Weeks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richa","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena S.","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0368-9950","authenticated-orcid":false,"given":"Laurens F.","family":"Tops","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa M.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1651-3620","authenticated-orcid":false,"given":"Amy","family":"Kiskaddon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamila","family":"Kremer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Keebler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi K.","family":"Ratnagiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.healun.2024.04.065_bib1","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.athoracsur.2022.11.023","article-title":"The Society of Thoracic Surgeons INTERMACS 2022 Annual Report: focus on the 2018 Heart Transplant Allocation System","volume":"115","author":"Yuzefpolskaya","year":"2023","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.healun.2024.04.065_bib2","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.healun.2017.05.008","article-title":"Bleeding and thrombosis associated with ventricular assist device therapy","volume":"36","author":"Shah","year":"2017","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.healun.2024.04.065_bib3","doi-asserted-by":"crossref","first-page":"S72","DOI":"10.1111\/jth.12961","article-title":"Medical device-induced thrombosis: what causes it and how can we prevent it?","volume":"13","author":"Jaffer","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.healun.2024.04.065_bib4","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1586\/17434440.6.1.51","article-title":"Surface coatings for ventricular assist devices","volume":"6","author":"Sin","year":"2009","journal-title":"Exp Rev Med Dev"},{"key":"10.1016\/j.healun.2024.04.065_bib5","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1111\/j.1525-1594.1997.tb00450.x","article-title":"Platelet damage caused by the centrifugal pump: in vitro evaluation by measuring the release of \u03b1-granule packing proteins","volume":"21","author":"Kawahito","year":"1997","journal-title":"Artif Organs"},{"key":"10.1016\/j.healun.2024.04.065_bib6","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/HCO.0000000000000284","article-title":"Bleeding and thrombosis in chronic ventricular assist device therapy: focus on platelets","volume":"31","author":"Koliopoulou","year":"2016","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.healun.2024.04.065_bib7","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s10555-017-9677-x","article-title":"Normal platelet function","volume":"36","author":"Holinstat","year":"2017","journal-title":"Cancer Metastas\u00a0Rev"},{"key":"10.1016\/j.healun.2024.04.065_bib8","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.jtcvs.2014.11.041","article-title":"Science for surgeons: understanding pump thrombogenesis in continuous-flow left ventricular assist devices","volume":"149","author":"Biasi","year":"2015","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.healun.2024.04.065_bib9","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1525-1594.2007.00391.x","article-title":"The effect of surface roughness on activation of the coagulation system and platelet adhesion in rotary blood pumps","volume":"31","author":"Linneweber","year":"2007","journal-title":"Artif Organs"},{"key":"10.1016\/j.healun.2024.04.065_bib10","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1510\/icvts.2010.232603","article-title":"Enhanced microparticles in ventricular assist device patients predict platelet, leukocyte and endothelial cell activation","volume":"11","author":"Diehl","year":"2010","journal-title":"Inter Cardiovasc Thorac Surg"},{"key":"10.1016\/j.healun.2024.04.065_bib11","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.115.002680","article-title":"Relationship between anticoagulation intensity and thrombotic or bleeding outcomes among outpatients with continuous-flow left ventricular assist devices","volume":"9","author":"Nassif","year":"2016","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.healun.2024.04.065_bib12","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.healun.2020.01.1330","article-title":"Understanding risk factors and predictors for stroke subtypes in the ENDURANCE trials","volume":"39","author":"Cho","year":"2020","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.healun.2024.04.065_bib13","unstructured":"Abbott Cardiovascular. Instructions for use website. \u3008https:\/\/manuals.sjm.com\/Search-Form?re=North-America&cc=US&ct=professional&ln=all\u3009, accessed April 4, 2023."},{"key":"10.1016\/j.healun.2024.04.065_bib14","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.healun.2018.03.002","article-title":"Evaluation of low-intensity anti-coagulation with a fully magnetically levitated centrifugal-flow circulatory pump\u2014the MAGENTUM 1 study","volume":"37","author":"Netuka","year":"2018","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.healun.2024.04.065_bib15","unstructured":"Medtronic. Medtronic HVAD system - ventricular assist devices. \u3008https:\/\/www.medtronic.com\/us-en\/healthcare-professionals\/products\/cardiac-rhythm\/ventricular-assist-devices\/hvad-system.html\u3009,\u00a0accessed April 4, 2023."},{"key":"10.1016\/j.healun.2024.04.065_bib16","first-page":"2334","article-title":"Rivaroxaban vs warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Rosenstein","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2024.04.065_bib17","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1378\/chest.129.5.1155","article-title":"Effect of study setting on anticoagulation control: a systematic review and metaregression","volume":"129","author":"Walraven","year":"2006","journal-title":"CHEST"},{"key":"10.1016\/j.healun.2024.04.065_bib18","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/aor.13116","article-title":"Meta-analysis of time in therapeutic range in continuous-flow left ventricular assist device patients receiving Warfarin","volume":"42","author":"Martinez","year":"2018","journal-title":"Artif Organs"},{"key":"10.1016\/j.healun.2024.04.065_bib19","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1002\/phar.2324","article-title":"Predictors of Warfarin time in therapeutic range after continuous-flow left ventricular assist device","volume":"39","author":"Henderson","year":"2019","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.healun.2024.04.065_bib20","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/MAT.0000000000000047","article-title":"Pharmacist-managed international normalized ratio patient self-testing is associated with increased time in therapeutic range in patients with left ventricular assist devices at an academic medical center","volume":"60","author":"Bishop","year":"2014","journal-title":"ASAIO J"},{"key":"10.1016\/j.healun.2024.04.065_bib21","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/MAT.0000000000000449","article-title":"Time in therapeutic range for left ventricular assist device patients anticoagulated with Warfarin: a correlation to clinical outcomes","volume":"63","author":"Halder","year":"2017","journal-title":"ASAIO J"},{"key":"10.1016\/j.healun.2024.04.065_bib22","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s11239-018-01800-x","article-title":"Impact of time in therapeutic range after left ventricular assist device placement: a comparison between thrombus and thrombus-free periods","volume":"47","author":"Lea","year":"2019","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.healun.2024.04.065_bib23","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ijcard.2016.05.030","article-title":"A multidisciplinary team-based process improves outpatient anticoagulation quality with continuous-flow left-ventricular assist devices","volume":"218","author":"Kuyumjian","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.healun.2024.04.065_bib24","first-page":"157","article-title":"International normalized ratio test frequency in left ventricular assist device patients affects anticoagulation quality and adverse events","volume":"67","author":"Schl\u00f6glhofer","year":"2021","journal-title":"ASAIO J Am Soc Artif Intern Organs 1992"},{"key":"10.1016\/j.healun.2024.04.065_bib25","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1055\/s-0040-1719153","article-title":"Benefit of self-managed anticoagulation in patients with left ventricular assist device","volume":"69","author":"Vogeler","year":"2021","journal-title":"Thorac Cardiovasc Surg"},{"key":"10.1016\/j.healun.2024.04.065_bib26","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1056\/NEJMoa1300615","article-title":"Dabigatran vs Warfarin in patients with mechanical heart valves","volume":"369","author":"Eikelboom","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2024.04.065_bib27","unstructured":"Terrovitis\u00a0JV,\u00a0Ntalianis\u00a0A,\u00a0Kapelios\u00a0CJ,\u00a0et al.\u00a0Dabigatran etexilate as second-line therapy in patients with a left ventricular assist device."},{"key":"10.1016\/j.healun.2024.04.065_bib28","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1007\/s11748-020-01371-w","article-title":"Factor Xa inhibitors in patients with continuous-flow left ventricular assist devices","volume":"68","author":"Parikh","year":"2020","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"10.1016\/j.healun.2024.04.065_bib29","article-title":"Increased thromboembolic events with dabigatran compared with vitamin K antagonism in left ventricular assist device patients","volume":"10","author":"Andreas","year":"2017","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.healun.2024.04.065_bib30","first-page":"318","article-title":"Apixaban: alternative anticoagulation for HeartMate 3 ventricular assist device","volume":"68","author":"Whitehouse","year":"2022","journal-title":"ASAIO J Am Soc Artif Intern Organs 1992"},{"key":"10.1016\/j.healun.2024.04.065_bib31","unstructured":"Shah P. Evaluation of the hemocompatibility of the direct oral anti-coagulant apixaban in left ventricular assist devices. clinicaltrials.gov; 2023. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04865978,\u00a0accessed April 3, 2023."},{"key":"10.1016\/j.healun.2024.04.065_bib32","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S1053-2498(00)00088-7","article-title":"Changes in platelet activation associated with left ventricular assist system placement","volume":"19","author":"Matsubayashi","year":"2000","journal-title":"J Heart Lung Transpl Publ Int Soc Heart Transpl"},{"key":"10.1016\/j.healun.2024.04.065_bib33","first-page":"459","article-title":"Increased leukocyte-platelet interactions during circulatory support with left ventricular assist devices","volume":"55","author":"Radovancevic","year":"2009","journal-title":"ASAIO J Am Soc Artif Intern Organs 1992"},{"key":"10.1016\/j.healun.2024.04.065_bib34","doi-asserted-by":"crossref","first-page":"461","DOI":"10.5301\/IJAO.2011.8459","article-title":"Platelet activation in heart failure patients supported by the HeartMate II ventricular assist device","volume":"34","author":"Slaughter","year":"2011","journal-title":"Int J Artif Organs"},{"key":"10.1016\/j.healun.2024.04.065_bib35","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.healun.2013.11.010","article-title":"Ambient hemolysis and activation of coagulation is different between HeartMate II and HeartWare left ventricular assist devices","volume":"33","author":"Birschmann","year":"2014","journal-title":"J Heart Lung Transpl Publ Int Soc Heart Transpl"},{"key":"10.1016\/j.healun.2024.04.065_bib36","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.athoracsur.2010.04.099","article-title":"Acquired von Willebrand syndrome in continuous-flow ventricular assist device recipients","volume":"90","author":"Crow","year":"2010","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.healun.2024.04.065_bib37","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jchf.2013.10.008","article-title":"Acquired von Willebrand syndrome in patients with a centrifugal or axial continuous flow left ventricular assist device","volume":"2","author":"Meyer","year":"2014","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.healun.2024.04.065_bib38","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1093\/ejcts\/ezz045","article-title":"Acquired von Willebrand factor deficiency is reduced in HeartMate 3 patients\u2020","volume":"56","author":"Klaeske","year":"2019","journal-title":"Eur J Cardio-Thorac Surg J Eur Assoc Cardio-Thorac Surg"},{"key":"10.1016\/j.healun.2024.04.065_bib39","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.healun.2016.05.019","article-title":"Evaluation of von Willebrand factor with a fully magnetically levitated centrifugal continuous-flow left ventricular assist device in advanced heart failure","volume":"35","author":"Netuka","year":"2016","journal-title":"J Heart Lung Transpl Publ Int Soc Heart Transpl"},{"key":"10.1016\/j.healun.2024.04.065_bib40","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1080\/09537104.2021.1881950","article-title":"Platelet activation and aggregation in different centrifugal-flow left ventricular assist devices","volume":"33","author":"Tscharre","year":"2022","journal-title":"Platelets"},{"key":"10.1016\/j.healun.2024.04.065_bib41","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000350469","article-title":"State of the art in platelet function testing","volume":"40","author":"Kehrel B","year":"2013","journal-title":"Transfus Med Hemotherapy Organ Dtsch Ges Transfus Immunhamatol"},{"key":"10.1016\/j.healun.2024.04.065_bib42","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1016\/j.jtcvs.2014.07.091","article-title":"Assessment of platelet function with light transmission aggregometry in 24 patients supported with a continuous-flow left ventricular assist device: a single-center experience","volume":"148","author":"Fiore","year":"2014","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.healun.2024.04.065_bib43","first-page":"578","article-title":"Assessment of bleeding and thrombosis based on aspirin responsiveness after continuous-flow left ventricular assist device placement","volume":"63","author":"Floroff","year":"2017","journal-title":"ASAIO J Am Soc Artif Intern Organs 1992"},{"key":"10.1016\/j.healun.2024.04.065_bib44","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.115.002296","article-title":"Antiplatelet therapy and adverse hematologic events during Heart Mate II support","volume":"9","author":"Saeed","year":"2016","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.healun.2024.04.065_bib45","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.healun.2013.12.001","article-title":"An analysis of pump thrombus events in patients in the HeartWare ADVANCE bridge to transplant and continued access protocol trial","volume":"33","author":"Najjar","year":"2014","journal-title":"J Heart Lung Transpl Publ Int Soc Heart Transpl"},{"key":"10.1016\/j.healun.2024.04.065_bib46","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.jchf.2015.05.011","article-title":"The HVAD left ventricular assist device: risk factors for neurological events and risk mitigation strategies","volume":"3","author":"Teuteberg","year":"2015","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.healun.2024.04.065_bib47","first-page":"e153","article-title":"Impact of aspirin dosing on thrombotic outcomes in patients with the HVAD","volume":"67","author":"Simone","year":"2021","journal-title":"ASAIO J Am Soc Artif Intern Organs 1992"},{"key":"10.1016\/j.healun.2024.04.065_bib48","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.healun.2020.03.001","article-title":"Effect of aspirin dose on hemocompatibility-related outcomes with a magnetically levitated left ventricular assist device: an analysis from the MOMENTUM 3 study","volume":"39","author":"Saeed","year":"2020","journal-title":"J Heart Lung Transpl Publ Int Soc Heart Transpl"},{"key":"10.1016\/j.healun.2024.04.065_bib49","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1056\/NEJMoa1014164","article-title":"Prospective trial of a pediatric ventricular assist device","volume":"367","author":"Fraser","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2024.04.065_bib50","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.healun.2020.02.007","article-title":"Early experience with the HeartMate 3 continuous-flow ventricular assist device in pediatric patients and patients with congenital heart disease: a multicenter registry analysis","volume":"39","author":"O\u2019Connor","year":"2020","journal-title":"J Heart Lung Transpl Publ Int Soc Heart Transpl"},{"key":"10.1016\/j.healun.2024.04.065_bib51","first-page":"683","article-title":"Management of antiplatelet therapy during continuous-flow left ventricular assist device support after thrombotic hemorrhagic events","volume":"65","author":"Gallo","year":"2019","journal-title":"ASAIO J Am Soc Artif Intern Organs 1992"},{"key":"10.1016\/j.healun.2024.04.065_bib52","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.athoracsur.2016.07.072","article-title":"Outcomes in HeartMate II patients with no antiplatelet therapy: 2-year results from the European TRACE study","volume":"103","author":"Netuka","year":"2017","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.healun.2024.04.065_bib53","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1097\/MAT.0000000000000561","article-title":"Warfarin and Aspirin vs Warfarin alone for prevention of embolic events in patients with a HeartMate II left ventricular assist device","volume":"63","author":"Van Tuyl","year":"2017","journal-title":"ASAIO J"},{"key":"10.1016\/j.healun.2024.04.065_bib54","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.healun.2020.05.003","article-title":"PREVENTion of non-surgical bleeding by management of HeartMate II patients without anti-platelet therapy (PREVENT II) trial","volume":"39","author":"Jorde","year":"2020","journal-title":"J Heart Lung Transpl Publ Int Soc Heart Transpl"},{"key":"10.1016\/j.healun.2024.04.065_bib55","first-page":"631","article-title":"Discontinuation of Aspirin in Heartmate 3 left ventricular assist device","volume":"65","author":"Lim","year":"2019","journal-title":"ASAIO J Am Soc Artif Intern Organs 1992"},{"key":"10.1016\/j.healun.2024.04.065_bib56","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/ejhf.1468","article-title":"Do we need aspirin in HeartMate 3 patients?","volume":"21","author":"Consolo","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.healun.2024.04.065_bib57","unstructured":"Yi\u00a0M,\u00a0Iyer\u00a0P,\u00a0Byku\u00a0M,\u00a0et al.\u00a0Warfarin and Aspirin vs Warfarin alone for prevention of bleeding and thrombotic events in patients with a HeartMate 3 left ventricular assist device. Artif Organs. doi:\u300810.1111\/aor.14652\u3009."},{"key":"10.1016\/j.healun.2024.04.065_bib58","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1001\/jama.2023.23204","article-title":"Aspirin and hemocompatibility events with a left ventricular assist device in advanced heart failure: the ARIES-HM3 randomized clinical trial","volume":"330","author":"Mehra","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.healun.2024.04.065_bib59","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.healun.2010.02.003","article-title":"Post-operative heparin may not be required for transitioning patients with a HeartMate II left ventricular assist system to long-term warfarin therapy","volume":"29","author":"Slaughter","year":"2010","journal-title":"J Heart Lung Transpl Publ Int Soc Heart Transpl"},{"key":"10.1016\/j.healun.2024.04.065_bib60","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.healun.2012.09.013","article-title":"The 2013 International Society for Heart and Lung Transplantation Guidelines for mechanical circulatory support: executive summary","volume":"32","author":"Feldman","year":"2013","journal-title":"J Heart Lung Transpl Publ Int Soc Heart Transpl"},{"key":"10.1016\/j.healun.2024.04.065_bib61","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1093\/ejcts\/ezz098","article-title":"2019 EACTS Expert Consensus on long-term mechanical circulatory support","volume":"56","author":"Potapov","year":"2019","journal-title":"Eur J Cardio-Thorac Surg J Eur Assoc Cardio-Thorac Surg"},{"key":"10.1016\/j.healun.2024.04.065_bib62","doi-asserted-by":"crossref","first-page":"521","DOI":"10.21037\/atm-20-4849","article-title":"Antiplatelet and anticoagulation strategies for left ventricular assist devices","volume":"9","author":"Loyaga-Rendon","year":"2021","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.healun.2024.04.065_bib63","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1186\/s13019-020-01373-y","article-title":"The use of enoxaparin as bridge to therapeutic INR after LVAD implantation","volume":"15","author":"Shah","year":"2020","journal-title":"J Cardiothorac Surg"},{"key":"10.1016\/j.healun.2024.04.065_bib64","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.healun.2013.10.009","article-title":"Low-molecular-weight heparin for anti-coagulation after left ventricular assist device implantation","volume":"33","author":"Sandner","year":"2014","journal-title":"J Heart Lung Transpl Publ Int Soc Heart Transpl"},{"key":"10.1016\/j.healun.2024.04.065_bib65","first-page":"123","article-title":"Comparison of anticoagulation strategies after left ventricular assist device implantation","volume":"62","author":"Kantorovich","year":"2016","journal-title":"ASAIO J Am Soc Artif Intern Organs 1992"},{"key":"10.1016\/j.healun.2024.04.065_bib66","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/01.ccm.0000619492.30172.d6","article-title":"284: Comparison of Bivalirudin vs Heparin as primary anticoagulation bridging post-LVAD implantation","volume":"48","author":"Milenkovich","year":"2020","journal-title":"Crit Care Med"},{"key":"10.1016\/j.healun.2024.04.065_bib67","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s40256-020-00450-w","article-title":"A review of Bivalirudin for pediatric and adult mechanical circulatory support","volume":"21","author":"Taylor","year":"2021","journal-title":"Am J Cardiovasc Drugs Drugs Devices Inter"},{"key":"10.1016\/j.healun.2024.04.065_bib68","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/ALN.0000000000001976","article-title":"Argatroban and Bivalirudin for perioperative anticoagulation in cardiac surgery","volume":"128","author":"Koster","year":"2018","journal-title":"Anesthesiology"},{"key":"10.1016\/j.healun.2024.04.065_bib69","first-page":"20","article-title":"Antithrombotic therapy in ventricular assist device (VAD) management: from ancient beliefs to updated evidence. A narrative review","volume":"20","author":"Morici","year":"2018","journal-title":"Int J Cardiol Heart Vasc"},{"key":"10.1016\/j.healun.2024.04.065_bib70","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s10047-015-0846-9","article-title":"Implantation of left ventricular assist devices under extracorporeal life support in patients with heparin-induced thrombocytopenia","volume":"18","author":"Hillebrand","year":"2015","journal-title":"J Artif Organs J Jpn Soc Artif Organs"},{"key":"10.1016\/j.healun.2024.04.065_bib71","first-page":"330","article-title":"Argatroban anticoagulation for heparin induced thrombocytopenia in patients with ventricular assist devices","volume":"78","author":"Pappalardo","year":"2012","journal-title":"Minerva Anestesiol"},{"key":"10.1016\/j.healun.2024.04.065_bib72","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1182\/asheducation-2018.1.507","article-title":"Adult and pediatric mechanical circulation: a guide for the hematologist","volume":"2018","author":"Kreuziger","year":"2018","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"10.1016\/j.healun.2024.04.065_bib73","first-page":"719","article-title":"Berlin heart EXCOR pediatric VAD IDE study investigators. Antithrombotic therapy in a prospective trial of a pediatric ventricular assist device","volume":"62","author":"Steiner","year":"2016","journal-title":"ASAIO J Am Soc Artif Intern Organs 1992"},{"key":"10.1016\/j.healun.2024.04.065_bib74","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.001429","article-title":"Neurological complications and outcomes in the Berlin Heart EXCOR\u00a0pediatric investigational device exemption trial","volume":"4","author":"Jordan","year":"2015","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.healun.2024.04.065_bib75","first-page":"939","article-title":"Utilization and outcomes of children treated with direct thrombin inhibitors on paracorporeal ventricular assist device support","volume":"66","author":"VanderPluym","year":"2020","journal-title":"ASAIO J Am Soc Artif Intern Organs 1992"},{"key":"10.1016\/j.healun.2024.04.065_bib76","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.healun.2021.01.010","article-title":"Berlin Heart EXCOR and ACTION post-approval surveillance study report","volume":"40","author":"Zafar","year":"2021","journal-title":"J Heart Lung Transpl Publ Int Soc Heart Transpl"},{"key":"10.1016\/j.healun.2024.04.065_bib77","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.healun.2014.08.022","article-title":"Activated partial thromboplastin time overestimates anti-coagulation in left ventricular assist device patients","volume":"33","author":"McIlvennan","year":"2014","journal-title":"J Heart Lung Transpl Publ Int Soc Heart Transpl"},{"key":"10.1016\/j.healun.2024.04.065_bib78","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.healun.2016.09.010","article-title":"Coagulation factor abnormalities related to discordance between anti-factor Xa and activated partial thromboplastin time in patients supported with continuous-flow left ventricular assist devices","volume":"35","author":"Adatya","year":"2016","journal-title":"J Heart Lung Transpl Publ Int Soc Heart Transpl"},{"key":"10.1016\/j.healun.2024.04.065_bib79","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.healun.2016.09.005","article-title":"Relationship of hemolysis with discordance in paired activated partial thromboplastin time and anti-Factor Xa measurements in continuous-flow left ventricular assist device patients","volume":"35","author":"Ton","year":"2016","journal-title":"J Heart Lung Transpl Publ Int Soc Heart Transpl"},{"key":"10.1016\/j.healun.2024.04.065_bib80","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.jchf.2014.11.009","article-title":"Anti-factor Xa and activated partial thromboplastin time measurements for heparin monitoring in mechanical circulatory support","volume":"3","author":"Adatya","year":"2015","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.healun.2024.04.065_bib81","first-page":"54","article-title":"Anticoagulant bridge comparison in mechanical circulatory support patients","volume":"65","author":"Cosgrove","year":"2019","journal-title":"ASAIO J Am Soc Artif Intern Organs 1992"},{"key":"10.1016\/j.healun.2024.04.065_bib82","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1515\/cclm-2020-0130","article-title":"Quality performance for indirect Xa inhibitor monitoring in patients using international external quality data","volume":"58","author":"Hollestelle","year":"2020","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.healun.2024.04.065_bib83","first-page":"318","article-title":"Fondaparinux monitoring: need for a local Fondaparinux-Calibrated Anti-F actor Xa assay","volume":"18","author":"Johnson","year":"2013","journal-title":"J Pedia Pharm Ther JPPT J PPAG"},{"key":"10.1016\/j.healun.2024.04.065_bib84","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1182\/bloodadvances.2018024489","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia","volume":"2","author":"Cuker","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.healun.2024.04.065_bib85","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.healun.2009.08.016","article-title":"Cardiac transplantation and\/or mechanical circulatory support device placement using heparin anti-coagulation in the presence of acute heparin-induced thrombocytopenia","volume":"29","author":"Zucker","year":"2010","journal-title":"J Heart Lung Transpl Publ Int Soc Heart Transpl"},{"key":"10.1016\/j.healun.2024.04.065_bib86","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1093\/icvts\/ivx251","article-title":"Bivalirudin anticoagulation for left ventricular assist device implantation on an extracorporeal life support system in patients with heparin-induced thrombocytopenia antibodies","volume":"25","author":"Ljajikj","year":"2017","journal-title":"Inter Cardiovasc Thorac Surg"},{"key":"10.1016\/j.healun.2024.04.065_bib87","doi-asserted-by":"crossref","first-page":"e439","DOI":"10.1016\/j.athoracsur.2019.09.056","article-title":"Plasmapheresis in patients with Heparin-induced thrombocytopenia requiring ventricular assist device","volume":"109","author":"Maffei","year":"2020","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.healun.2024.04.065_bib88","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.athoracsur.2017.06.031","article-title":"Abciximab\/Heparin Therapy for left ventricular assist device implantation in patients with Heparin-induced thrombocytopenia","volume":"105","author":"Lee","year":"2018","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.healun.2024.04.065_bib89","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13019-018-0721-x","article-title":"The use of cangrelor with heparin for left ventricular assist device implantation in a patient with acute heparin-induced thrombocytopenia","volume":"13","author":"Gernhofer","year":"2018","journal-title":"J Cardiothorac Surg"},{"key":"10.1016\/j.healun.2024.04.065_bib90","first-page":"e152","article-title":"Management of Heparin-induced thrombocytopenia using plasmapharesis in patients undergoing HeartMate 3 left ventricular assist device","volume":"68","author":"Naqvi","year":"2022","journal-title":"ASAIO J Am Soc Artif Intern Organs 1992"},{"key":"10.1016\/j.healun.2024.04.065_bib91","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.118.005267","article-title":"Novel model to predict gastrointestinal bleeding during left ventricular assist device support","volume":"11","author":"Yin","year":"2018","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.healun.2024.04.065_bib92","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.healun.2015.01.981","article-title":"Bridging with half-therapeutic dose enoxaparin in outpatients with left ventricular assist devices and sub-therapeutic international normalized ratios","volume":"34","author":"Borden","year":"2015","journal-title":"J Heart Lung Transpl Publ Int Soc Heart Transpl"},{"key":"10.1016\/j.healun.2024.04.065_bib93","first-page":"140","article-title":"Increased risk of bleeding in left ventricular assist device patients treated with Enoxaparin as bridge to therapeutic international normalized ratio","volume":"64","author":"Bhatia","year":"2018","journal-title":"ASAIO J Am Soc Artif Intern Organs 1992"},{"key":"10.1016\/j.healun.2024.04.065_bib94","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.healun.2013.07.015","article-title":"Fondaparinux: an effective bridging strategy in heparin-induced thrombocytopenia and mechanical circulatory support","volume":"33","author":"Gellatly","year":"2014","journal-title":"J Heart Lung Transpl Publ Int Soc Heart Transpl"},{"key":"10.1016\/j.healun.2024.04.065_bib95","doi-asserted-by":"crossref","first-page":"e24S","DOI":"10.1378\/chest.11-2291","article-title":"Parenteral anticoagulants: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of\u00a0Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Garcia","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.healun.2024.04.065_bib96","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/eurheartj\/ehx036","article-title":"The burden of haemocompatibility with left ventricular assist systems: a complex weave","volume":"40","author":"Mehra","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.healun.2024.04.065_bib97","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.healun.2016.10.001","article-title":"PREVENtion of HeartMate II pump thrombosis through clinical management: the PREVENT multi-center study","volume":"36","author":"Maltais","year":"2017","journal-title":"J Heart Lung Transpl Publ Int Soc Heart Transpl"},{"key":"10.1016\/j.healun.2024.04.065_bib98","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.healun.2014.07.002","article-title":"Prior hematologic conditions carry a high morbidity and mortality in patients supported with continuous-flow left ventricular assist devices","volume":"33","author":"Fried","year":"2014","journal-title":"J Heart Lung Transpl Publ Int Soc Heart Transpl"},{"key":"10.1016\/j.healun.2024.04.065_bib99","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.healun.2004.08.011","article-title":"Antiphospholipid syndrome with anti-prothrombin autoantibodies in a patient with an axial-flow left ventricular assist device","volume":"24","author":"Wadia","year":"2005","journal-title":"J Heart Lung Transpl Publ Int Soc Heart Transpl"},{"key":"10.1016\/j.healun.2024.04.065_bib100","first-page":"417","article-title":"Left ventricular assist device-associated carbon monoxide and iron-enhanced hypercoagulation: impact of concurrent disease","volume":"61","author":"Nielsen","year":"2015","journal-title":"ASAIO J Am Soc Artif Intern Organs 1992"},{"key":"10.1016\/j.healun.2024.04.065_bib101","first-page":"448","article-title":"Early signatures of bleeding and mortality in patients on left ventricular assist device support: novel methods for personalized risk-stratification","volume":"24","author":"Shrout","year":"2019","journal-title":"Biomark Biochem Indic Expo Response Susceptibility Chem"},{"key":"10.1016\/j.healun.2024.04.065_bib102","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.cardfail.2015.12.020","article-title":"Acquired and hereditary hypercoagulable states in patients with continuous flow left ventricular assist devices: prevalence and thrombotic complications","volume":"22","author":"Alvarez","year":"2016","journal-title":"J Card Fail"},{"key":"10.1016\/j.healun.2024.04.065_bib103","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.healun.2015.10.024","article-title":"Pump thrombosis in the thoratec HeartMate II device: an update analysis of the INTERMACS registry","volume":"34","author":"Kirklin","year":"2015","journal-title":"J Heart Lung Transpl Publ Int Soc Heart Transpl"},{"key":"10.1016\/j.healun.2024.04.065_bib104","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.120.006910","article-title":"Psychosocial risk and its association with outcomes in continuous-flow left ventricular assist device patients","volume":"13","author":"DeFilippis","year":"2020","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.healun.2024.04.065_bib105","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.healun.2013.07.020","article-title":"Gastrointestinal bleeding and subsequent risk of thromboembolic events during support with a left ventricular assist device","volume":"33","author":"Stulak","year":"2014","journal-title":"J Heart Lung Transpl Publ Int Soc Heart Transpl"},{"key":"10.1016\/j.healun.2024.04.065_bib106","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s10047-020-01228-2","article-title":"Identification of characteristics, risk factors, and predictors of recurrent LVAD thrombosis: conditions in HeartWare devices","volume":"24","author":"Gyoten","year":"2021","journal-title":"J Artif Organs J Jpn Soc Artif Organs"},{"key":"10.1016\/j.healun.2024.04.065_bib107","first-page":"640","article-title":"Predictors of thromboembolic events in patients with ventricular assist device","volume":"61","author":"Boehme","year":"2015","journal-title":"ASAIO J Am Soc Artif Intern Organs 1992"},{"key":"10.1016\/j.healun.2024.04.065_bib108","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.healun.2016.12.010","article-title":"Risk factors, mortality, and timing of ischemic and hemorrhagic stroke with left ventricular assist devices","volume":"36","author":"Frontera","year":"2017","journal-title":"J Heart Lung Transpl Publ Int Soc Heart Transpl"},{"key":"10.1016\/j.healun.2024.04.065_bib109","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/ejhf.1372","article-title":"Optimal haemodynamics during left ventricular assist device support are associated with reduced haemocompatibility-related adverse events","volume":"21","author":"Imamura","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.healun.2024.04.065_bib110","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.cardfail.2019.08.003","article-title":"Aortic insufficiency and hemocompatibility-related adverse events in patients with left ventricular assist devices","volume":"25","author":"Imamura","year":"2019","journal-title":"J Card Fail"},{"key":"10.1016\/j.healun.2024.04.065_bib111","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.014801","article-title":"Decoupling between diastolic pulmonary artery and pulmonary capillary wedge pressures is associated with right ventricular dysfunction and hemocompatibility-related adverse events in patients with left ventricular assist devices","volume":"9","author":"Imamura","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.healun.2024.04.065_bib112","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.healun.2016.01.021","article-title":"Clinical trial design and rationale of the Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) investigational device exemption clinical study protocol","volume":"35","author":"Heatley","year":"2016","journal-title":"J Heart Lung Transpl Publ Int Soc Heart Transpl"},{"key":"10.1016\/j.healun.2024.04.065_bib113","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1056\/NEJMoa1900486","article-title":"A fully magnetically levitated left ventricular assist device - final report","volume":"380","author":"Mehra","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2024.04.065_bib114","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.athoracsur.2019.12.005","article-title":"The society of thoracic surgeons INTERMACS 2019 annual report: the changing landscape of devices and indications","volume":"109","author":"Teuteberg","year":"2020","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.healun.2024.04.065_bib115","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.healun.2017.06.017","article-title":"Second annual Pediatric Interagency Registry for Mechanical Circulatory Support (Pedimacs) report: pre-implant characteristics and outcomes","volume":"37","author":"Blume","year":"2018","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.healun.2024.04.065_bib116","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/MAT.0000000000001373","article-title":"HVAD usage and outcomes in the current pediatric ventricular assist device field: an Advanced Cardiac Therapies Improving Outcomes Network (ACTION) analysis","volume":"67","author":"Auerbach","year":"2021","journal-title":"ASAIO J"},{"key":"10.1016\/j.healun.2024.04.065_bib117","article-title":"Predicting bleeding and thrombosis complications in patients with continuous flow left ventricular assist devices","volume":"6","author":"Zacholski","year":"2020","journal-title":"VAD J"},{"key":"10.1016\/j.healun.2024.04.065_bib118","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1177\/0391398818762353","article-title":"Prospective analysis of bleeding events in left ventricular assist device patients","volume":"41","author":"Sherazi","year":"2018","journal-title":"Int J Artif Organs"},{"key":"10.1016\/j.healun.2024.04.065_bib119","doi-asserted-by":"crossref","DOI":"10.11589\/vad\/e20206261","article-title":"Evaluation of outpatient anticoagulation bridging after left ventricular assist device implantation","volume":"6","author":"Rainess","year":"2020","journal-title":"VAD J"},{"key":"10.1016\/j.healun.2024.04.065_bib120","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/j.cardfail.2018.07.082","article-title":"Effect of Enoxaparin on bleeding and thrombosis in patients supported with ventricular assist devices","volume":"24","author":"Masic","year":"2018","journal-title":"J Card Fail"},{"key":"10.1016\/j.healun.2024.04.065_bib121","doi-asserted-by":"crossref","first-page":"957","DOI":"10.2217\/fca-2022-0054","article-title":"Predictors of gastrointestinal bleeding in patients following left ventricular assist device implantation: a systematic review and meta-analysis","volume":"18","author":"Gangwani","year":"2022","journal-title":"Future Cardiol"},{"key":"10.1016\/j.healun.2024.04.065_bib122","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1056\/NEJMoa1610426","article-title":"A fully magnetically levitated circulatory pump for advanced heart failure","volume":"376","author":"Mehra","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2024.04.065_bib123","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1056\/NEJMoa1800866","article-title":"Two-year outcomes with a magnetically levitated cardiac pump in heart failure","volume":"378","author":"Mehra","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2024.04.065_bib124","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.healun.2020.03.010","article-title":"Updated definitions of adverse events for trials and registries of mechanical circulatory support: a consensus statement of the mechanical circulatory support academic research consortium","volume":"39","author":"Kormos","year":"2020","journal-title":"J Heart Lung Transpl Publ Int Soc Heart Transpl"},{"key":"10.1016\/j.healun.2024.04.065_bib125","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1161\/CIRCULATIONAHA.118.037231","article-title":"Comprehensive analysis of stroke in the long-term cohort of the MOMENTUM 3 study","volume":"139","author":"Colombo","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2024.04.065_bib126","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1093\/eurheartj\/ehaa639","article-title":"Two-year outcome after implantation of a full magnetically levitated left ventricular assist device: results from the ELEVATE registry","volume":"41","author":"Zimpfer","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.healun.2024.04.065_bib127","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.healun.2020.06.012","article-title":"Two-year outcome of warfarin monotherapy in HeartMate 3 left ventricular assist device: a single-center experience","volume":"39","author":"Lim","year":"2020","journal-title":"J Heart Lung Transpl Publ Int Soc Heart Transpl"},{"key":"10.1016\/j.healun.2024.04.065_bib128","first-page":"373","article-title":"Medical management of pump-related thrombosis in patients with continuous-flow left ventricular assist devices: a systematic review and meta-analysis","volume":"63","author":"Dang","year":"2017","journal-title":"ASAIO J Am Soc Artif Intern Organs 1992"},{"key":"10.1016\/j.healun.2024.04.065_bib129","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1177\/0391398819896585","article-title":"Initial conservative management strategy of HeartWare left ventricular assist device thrombosis with intravenous heparin or bivalirudin","volume":"43","author":"Bouzas-Cruz","year":"2020","journal-title":"Int J Artif Organs"},{"key":"10.1016\/j.healun.2024.04.065_bib130","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1007\/s11239-018-1725-z","article-title":"Bivalirudin for left ventricular assist device thrombosis","volume":"46","author":"Weeks","year":"2018","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.healun.2024.04.065_bib131","first-page":"744","article-title":"Bivalirudin for treatment of LVAD thrombosis: a case series","volume":"60","author":"Sylvia","year":"2014","journal-title":"ASAIO J Am Soc Artif Intern Organs 1992"},{"key":"10.1016\/j.healun.2024.04.065_bib132","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1111\/aor.12910","article-title":"The use of Eptifibatide alone or in combination with Heparin or Argatroban for suspected thrombosis in patients with left ventricular assist devices","volume":"41","author":"Bitar","year":"2017","journal-title":"Artif Organs"},{"key":"10.1016\/j.healun.2024.04.065_bib133","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.healun.2013.11.002","article-title":"The use of eptifibatide for suspected pump thrombus or thrombosis in patients with left ventricular assist devices","volume":"33","author":"Tellor","year":"2014","journal-title":"J Heart Lung Transpl Publ Int Soc Heart Transpl"},{"key":"10.1016\/j.healun.2024.04.065_bib134","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.ccl.2018.06.008","article-title":"Antithrombotic strategies and device thrombosis","volume":"36","author":"Gurbel","year":"2018","journal-title":"Cardiol Clin"},{"key":"10.1016\/j.healun.2024.04.065_bib135","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s40256-014-0102-3","article-title":"Management of pump thrombosis in patients with left ventricular assist devices","volume":"15","author":"Stulak","year":"2015","journal-title":"Am J Cardiovasc Drugs Drugs Devices Inter"},{"key":"10.1016\/j.healun.2024.04.065_bib136","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.jtcvs.2010.11.022","article-title":"Management of HeartWare left ventricular assist device thrombosis using intracavitary thrombolytics","volume":"142","author":"Kiernan","year":"2011","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.healun.2024.04.065_bib137","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1161\/CIRCHEARTFAILURE.113.000013","article-title":"Treatment of left ventricular assist device thrombosis with extended catheter-directed intraventricular thrombolytic therapy","volume":"6","author":"Thenappan","year":"2013","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.healun.2024.04.065_bib138","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/jocs.12238","article-title":"Diagnosis, nonsurgical management, and prevention of LVAD thrombosis","volume":"29","author":"Bartoli","year":"2014","journal-title":"J Card Surg"},{"key":"10.1016\/j.healun.2024.04.065_bib139","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1161\/STROKEAHA.118.022967","article-title":"Stroke incidence and impact of continuous-flow left ventricular assist devices on cerebrovascular physiology","volume":"50","author":"Cornwell","year":"2019","journal-title":"Stroke"},{"key":"10.1016\/j.healun.2024.04.065_bib140","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1161\/STR.0000000000000158","article-title":"2018 Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"49","author":"Powers","year":"2018","journal-title":"Stroke"},{"key":"10.1016\/j.healun.2024.04.065_bib141","doi-asserted-by":"crossref","first-page":"e344","DOI":"10.1161\/STROKEAHA.118.022606","volume":"50","author":"Powers","year":"2019","journal-title":"Stroke"},{"key":"10.1016\/j.healun.2024.04.065_bib142","doi-asserted-by":"crossref","first-page":"I","DOI":"10.1177\/23969873221100032","article-title":"European Stroke Organisation (ESO) guideline on pharmacological interventions for long-term secondary prevention after ischaemic stroke or transient ischaemic attack","volume":"7","author":"Dawson","year":"2022","journal-title":"Eur Stroke J"},{"key":"10.1016\/j.healun.2024.04.065_bib143","doi-asserted-by":"crossref","first-page":"I","DOI":"10.1177\/2396987321989865","article-title":"European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke","volume":"6","author":"Berge","year":"2021","journal-title":"Eur Stroke J"},{"key":"10.1016\/j.healun.2024.04.065_bib144","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1136\/svn-2020-000378","article-title":"Chinese Stroke Association guidelines for clinical management of cerebrovascular disorders: executive summary and 2019 update of clinical management of ischaemic cerebrovascular diseases","volume":"5","author":"Liu","year":"2020","journal-title":"Stroke Vasc Neurol"},{"key":"10.1016\/j.healun.2024.04.065_bib145","article-title":"Management of ischemic stroke following left ventricular assist device","volume":"29","author":"Rettenmaier","year":"2020","journal-title":"J Stroke Cereb Dis J Natl Stroke Assoc"},{"key":"10.1016\/j.healun.2024.04.065_bib146","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.athoracsur.2020.12.038","article-title":"The society of thoracic surgeons INTERMACS 2020 annual report","volume":"111","author":"Molina","year":"2021","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.healun.2024.04.065_bib147","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.healun.2019.05.006","article-title":"Effects of a fully magnetically levitated centrifugal-flow or axial-flow left ventricular assist device on von Willebrand factor: a prospective multicenter clinical trial","volume":"38","author":"Bansal","year":"2019","journal-title":"J Heart Lung Transpl Publ Int Soc Heart Transpl"},{"key":"10.1016\/j.healun.2024.04.065_bib148","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1111\/aor.13725","article-title":"Characteristics and outcomes of gastrointestinal bleeding in patients with continuous-flow left ventricular assist devices: a systematic review","volume":"44","author":"Carlson","year":"2020","journal-title":"Artif Organs"},{"key":"10.1016\/j.healun.2024.04.065_bib149","doi-asserted-by":"crossref","first-page":"e44S","DOI":"10.1378\/chest.11-2292","article-title":"Oral anticoagulant therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of\u00a0Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Ageno","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.healun.2024.04.065_bib150","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1001\/archinte.163.20.2469","article-title":"Comparison of oral vs intravenous phytonadione (vitamin K1) in patients with excessive anticoagulation: a prospective randomized controlled study","volume":"163","author":"Lubetsky","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.healun.2024.04.065_bib151","doi-asserted-by":"crossref","first-page":"e152S","DOI":"10.1378\/chest.11-2295","article-title":"Evidence-based management of anticoagulant therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of\u00a0Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Holbrook","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.healun.2024.04.065_bib152","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s12028-015-0222-x","article-title":"Guideline for reversal of antithrombotics in intracranial hemorrhage: a statement for healthcare professionals from the neurocritical care society and society of critical care medicine","volume":"24","author":"Frontera","year":"2016","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.healun.2024.04.065_bib153","first-page":"381","article-title":"Safety of anticoagulation reversal in patients supported with continuous-flow left ventricular assist devices","volume":"60","author":"Jennings","year":"2014","journal-title":"ASAIO J Am Soc Artif Intern Organs 1992"},{"key":"10.1016\/j.healun.2024.04.065_bib154","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/j.cardfail.2020.09.129","article-title":"Efficacy and safety of low-dose intravenous vitamin K for international normalized ratio reversal in left ventricular assist device patients","volume":"26","author":"Patel","year":"2020","journal-title":"J Card Fail"},{"key":"10.1016\/j.healun.2024.04.065_bib155","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1111\/pan.14287","article-title":"Neurosurgical intervention in children with ventricular assist devices: a single-center case series review","volume":"31","author":"Yu","year":"2021","journal-title":"Paediatr Anaesth"},{"key":"10.1016\/j.healun.2024.04.065_bib156","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1161\/CIRCULATIONAHA.113.002283","article-title":"Efficacy and safety of a 4-factor prothrombin complex concentrate in patients on vitamin K antagonists presenting with major bleeding: a randomized, plasma-controlled, phase IIIb study","volume":"128","author":"Sarode","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2024.04.065_bib157","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1161\/CIRCULATIONAHA.113.001875","article-title":"Outcomes of urgent Warfarin reversal with frozen plasma vs prothrombin complex concentrate in the emergency department","volume":"128","author":"Hickey","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2024.04.065_bib158","first-page":"e8","article-title":"Prothrombin complex concentrate use in durable and short-term left ventricular assist device implantation","volume":"66","author":"Barac","year":"2020","journal-title":"ASAIO J Am Soc Artif Intern Organs 1992"},{"key":"10.1016\/j.healun.2024.04.065_bib159","doi-asserted-by":"crossref","first-page":"E223","DOI":"10.1111\/aor.13918","article-title":"Intraoperative prothrombin complex concentrate administration and outcomes in patients undergoing left ventricular assist device implantation","volume":"45","author":"Boswell","year":"2021","journal-title":"Artif Organs"},{"key":"10.1016\/j.healun.2024.04.065_bib160","first-page":"509","article-title":"Safety of prothombin complex concentrate to control excess bleeding during continuous flow LVAD insertion","volume":"61","author":"Bradford","year":"2015","journal-title":"ASAIO J Am Soc Artif Intern Organs 1992"},{"key":"10.1016\/j.healun.2024.04.065_bib161","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1002\/ehf2.12780","article-title":"The effect of transfusion of blood products on ventricular assist device support outcomes","volume":"7","author":"Shore","year":"2020","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.healun.2024.04.065_bib162","doi-asserted-by":"crossref","first-page":"531","DOI":"10.12659\/AOT.898496","article-title":"4-Factor Prothrombin Complex Concentrate (PCC4, Kcentra) protocol reduces blood requirements for heart transplantation: a novel protocol","volume":"21","author":"Pratt Cleary","year":"2016","journal-title":"Ann Transpl"},{"key":"10.1016\/j.healun.2024.04.065_bib163","first-page":"649","article-title":"Anticoagulation reversal and risk of thromboembolic events among heart transplant recipients bridged with durable mechanical circulatory support devices","volume":"65","author":"Moretz","year":"2019","journal-title":"ASAIO J Am Soc Artif Intern Organs 1992"},{"key":"10.1016\/j.healun.2024.04.065_bib164","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.transproceed.2015.02.008","article-title":"Case series of 4-factor prothrombin complex concentrate for warfarin reversal before heart transplantation","volume":"47","author":"Nuckles","year":"2015","journal-title":"Transpl Proc"},{"key":"10.1016\/j.healun.2024.04.065_bib165","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1053\/j.jvca.2017.08.011","article-title":"Intraoperative administration of 4-factor prothrombin complex concentrate reduces blood requirements in cardiac transplantation","volume":"32","author":"Sun","year":"2018","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.healun.2024.04.065_bib166","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.athoracsur.2017.10.044","article-title":"Impact of prothrombin complex concentrate on blood use, cost, and outcomes in heart transplantation","volume":"105","author":"Wu","year":"2018","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.healun.2024.04.065_bib167","first-page":"552","article-title":"Anticoagulation reversal strategies for left ventricular assist device patients presenting with acute intracranial hemorrhage","volume":"62","author":"Wong","year":"2016","journal-title":"ASAIO J Am Soc Artif Intern Organs 1992"},{"key":"10.1016\/j.healun.2024.04.065_bib168","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s11239-018-1680-8","article-title":"Four factor prothrombin complex concentrate for warfarin reversal in patients with left ventricular assist devices","volume":"46","author":"Rimsans","year":"2018","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.healun.2024.04.065_bib169","first-page":"e21","article-title":"Low-dose prothrombin complex concentrate in patients with left ventricular assist devices","volume":"65","author":"Brown","year":"2019","journal-title":"ASAIO J Am Soc Artif Intern Organs 1992"},{"key":"10.1016\/j.healun.2024.04.065_bib170","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1007\/s12028-021-01210-7","article-title":"Prothrombin complex concentrate for emergent reversal of intracranial hemorrhage in patients with ventricular assist devices","volume":"35","author":"Lai","year":"2021","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.healun.2024.04.065_bib171","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1177\/1089253220949386","article-title":"Management of a pediatric patient with a left ventricular assist device and symptomatic acquired von Willebrand syndrome presenting for orthotopic heart transplant","volume":"24","author":"Flannery","year":"2020","journal-title":"Semin Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.healun.2024.04.065_bib172","first-page":"127","article-title":"Prothrombin complex concentrate and methylene blue for treatment of coagulopathy and Vasoplegia in a pediatric heart transplant patient","volume":"6","author":"Lee","year":"2016","journal-title":"Case Rep"},{"key":"10.1016\/j.healun.2024.04.065_bib173","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/aor.12209","article-title":"Incidence and outcome of pediatric patients with intracranial hemorrhage while supported on ventricular assist devices","volume":"38","author":"Niebler","year":"2014","journal-title":"Artif Organs"},{"key":"10.1016\/j.healun.2024.04.065_bib174","first-page":"E135","article-title":"Management of intracranial hemorrhage in a child with a left ventricular assist device","volume":"16","author":"Haque","year":"2012","journal-title":"Pedia Transpl"},{"key":"10.1016\/j.healun.2024.04.065_bib175","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.athoracsur.2006.10.033","article-title":"Recombinant activated factor VII in cardiac surgery: a systematic review","volume":"83","author":"Warren","year":"2007","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.healun.2024.04.065_bib176","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.healun.2009.04.028","article-title":"High incidence of thromboembolic events in left ventricular assist device patients treated with recombinant activated factor VII","volume":"28","author":"Bruckner","year":"2009","journal-title":"J Heart Lung Transpl Publ Int Soc Heart Transpl"},{"key":"10.1016\/j.healun.2024.04.065_bib177","doi-asserted-by":"crossref","first-page":"4503","DOI":"10.1111\/jocs.16003","article-title":"Evaluation of Aspirin platelet inhibition in left ventricular assist device population","volume":"36","author":"Morgan","year":"2021","journal-title":"J Card Surg"},{"key":"10.1016\/j.healun.2024.04.065_bib178","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.CIR.101.10.1206","article-title":"Aspirin","volume":"101","author":"Awtry","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2024.04.065_bib179","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.healun.2015.06.018","article-title":"Safety of reduced anti-thrombotic strategies in HeartMate II patients: a one-year analysis of the US-TRACE study","volume":"34","author":"Katz","year":"2015","journal-title":"J Heart Lung Transpl Publ Int Soc Heart Transpl"},{"key":"10.1016\/j.healun.2024.04.065_bib180","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1111\/aor.13705","article-title":"The influence of left ventricular assist device inflow cannula position on thrombosis risk","volume":"44","author":"Ghodrati","year":"2020","journal-title":"Artif Organs"},{"key":"10.1016\/j.healun.2024.04.065_bib181","first-page":"227","article-title":"Pump position impacts HeartMate II left ventricular assist device thrombosis","volume":"65","author":"Kilic","year":"2019","journal-title":"ASAIO J Am Soc Artif Intern Organs 1992"},{"key":"10.1016\/j.healun.2024.04.065_bib182","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/jocs.12478","article-title":"Principles of HeartMate II implantation to avoid pump malposition and migration","volume":"30","author":"Adamson","year":"2015","journal-title":"J Card Surg"},{"key":"10.1016\/j.healun.2024.04.065_bib183","doi-asserted-by":"crossref","first-page":"131","DOI":"10.31486\/toj.17.0070","article-title":"Left ventricular assist device inflow cannula position may contribute to the development of HeartMate II left ventricular assist device pump thrombosis","volume":"18","author":"Bhama","year":"2018","journal-title":"Ochsner J"},{"key":"10.1016\/j.healun.2024.04.065_bib184","first-page":"701","article-title":"Repeated Ramp Tests on stable LVAD patients reveal patient-specific hemodynamic fingerprint","volume":"64","author":"Imamura","year":"2018","journal-title":"ASAIO J Am Soc Artif Intern Organs 1992"},{"key":"10.1016\/j.healun.2024.04.065_bib185","first-page":"266","article-title":"Pump speed optimization in stable patients with a left ventricular assist device","volume":"63","author":"Couperus","year":"2017","journal-title":"ASAIO J Am Soc Artif Intern Organs 1992"},{"key":"10.1016\/j.healun.2024.04.065_bib186","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1002\/ccd.29785","article-title":"Outflow graft obstruction in patients with the HM 3 LVAD: a percutaneous approach","volume":"98","author":"Milwidsky","year":"2021","journal-title":"Catheter Cardiovasc Inter J Soc Card Angiogr Inter"},{"key":"10.1016\/j.healun.2024.04.065_bib187","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1111\/jocs.14878","article-title":"Surgical treatment of outflow graft kinking complicated by external obstruction with a fibrin mass in a patient with LVAD","volume":"35","author":"Nersesian","year":"2020","journal-title":"J Card Surg"},{"key":"10.1016\/j.healun.2024.04.065_bib188","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1002\/ehf2.13333","article-title":"Outflow graft obstruction after left ventricular assist device implantation: a retrospective, single-centre case series","volume":"8","author":"Agrawal","year":"2021","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.healun.2024.04.065_bib189","first-page":"128","article-title":"LVAD outflow graft role in pump thrombosis","volume":"66","author":"Barac","year":"2020","journal-title":"ASAIO J Am Soc Artif Intern Organs 1992"},{"key":"10.1016\/j.healun.2024.04.065_bib190","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1016\/j.jcmg.2019.11.018","article-title":"Computed tomography and fluoroscopic angiography in management of left ventricular assist device outflow graft obstruction","volume":"13","author":"Wamala","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.healun.2024.04.065_bib191","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/j.athoracsur.2017.03.065","article-title":"Implantation of a durable left ventricular assist device: how i teach it","volume":"103","author":"Stulak","year":"2017","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.healun.2024.04.065_bib192","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.jchf.2018.05.012","article-title":"HVAD: the ENDURANCE supplemental trial","volume":"6","author":"Milano","year":"2018","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.healun.2024.04.065_bib193","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.healun.2019.11.016","article-title":"Outcomes based on blood pressure in patients on continuous flow left ventricular assist device support: an interagency registry for mechanically assisted circulatory support analysis","volume":"39","author":"Cowger","year":"2020","journal-title":"J Heart Lung Transpl Publ Int Soc Heart Transpl"},{"key":"10.1016\/j.healun.2024.04.065_bib194","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s11906-017-0782-6","article-title":"The unique blood pressures and pulsatility of LVAD patients: current challenges and future opportunities","volume":"19","author":"Castagna","year":"2017","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.healun.2024.04.065_bib195","first-page":"374","article-title":"Variability in blood pressure assessment in patients supported with the HeartMate 3TM","volume":"68","author":"Cowger","year":"2022","journal-title":"ASAIO J Am Soc Artif Intern Organs 1992"},{"key":"10.1016\/j.healun.2024.04.065_bib196","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.athoracsur.2018.09.004","article-title":"Left atrial appendage occlusion with left ventricular assist device decreases thromboembolic events","volume":"107","author":"Deshmukh","year":"2019","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.healun.2024.04.065_bib197","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.healun.2016.03.003","article-title":"Preoperative atrial fibrillation may not increase thromboembolic events in left ventricular assist device recipients on midterm follow-up","volume":"35","author":"Xia","year":"2016","journal-title":"J Heart Lung Transpl Publ Int Soc Heart Transpl"},{"key":"10.1016\/j.healun.2024.04.065_bib198","first-page":"456","article-title":"Atrial fibrillation is not associated with thromboembolism in left ventricular assist device patients: a systematic review and meta-analysis","volume":"65","author":"Kittipibul","year":"2019","journal-title":"ASAIO J Am Soc Artif Intern Organs 1992"},{"key":"10.1016\/j.healun.2024.04.065_bib199","first-page":"325","article-title":"Impact of preoperative atrial fibrillation on thromboembolic events and pump thrombosis in long-term left ventricular assist device therapy","volume":"57","author":"Pedde","year":"2020","journal-title":"Eur J Cardio-Thorac Surg J Eur Assoc Cardio-Thorac Surg"},{"key":"10.1016\/j.healun.2024.04.065_bib200","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1016\/j.jacc.2014.07.989","article-title":"Clinical impact of atrial fibrillation in patients with the HeartMate II left ventricular assist device","volume":"64","author":"Enriquez","year":"2014","journal-title":"J Am Coll Cardiol"}],"container-title":["The Journal of Heart and Lung Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249824016462?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249824016462?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T06:31:43Z","timestamp":1720765903000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053249824016462"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":200,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S1053249824016462"],"URL":"https:\/\/doi.org\/10.1016\/j.healun.2024.04.065","relation":{},"ISSN":["1053-2498"],"issn-type":[{"value":"1053-2498","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An ISHLT consensus statement on strategies to prevent\u00a0and manage hemocompatibility related adverse events in patients with a durable, continuous-flow ventricular assist device","name":"articletitle","label":"Article Title"},{"value":"The Journal of Heart and Lung Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.healun.2024.04.065","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 International Society for Heart and Lung Transplantation. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}